Mr. Abrams advises health care organizations and corporate clients on complex transactions, including mergers and acquisitions, divestitures, corporate reorganizations, and regulatory compliance. His work spans health care systems, behavioral health companies, physician practices, and corporate entities, with experience ranging from single-asset acquisitions to large-scale system transactions. He focuses on structuring transactions, negotiating definitive agreements, and supervising multidisciplinary teams across real estate, employment, data privacy, intellectual property, and health care regulatory disciplines. Mr. Abrams is known for his ability to coordinate transactions involving numerous stakeholders and competing interests and takes pride in understanding his clients' business objectives and designing creative, yet practical, legal solutions to meet their needs.
Mr. Abrams represents a diverse range of clients across the health care and corporate sectors, including major not-for-profit health systems, investor-owned hospital companies, behavioral health organizations, and physician practices. His transactional experience spans deal structures of varying size and complexity, and he is equally adept at representing buyers and sellers across a wide spectrum of industries and ownership models.
Mr. Abrams brings particular depth to transactions involving complex regulatory environments, including Certificate of Public Advantage (COPA) proceedings. His experience navigating the intersection of health care regulation and transactional law allows him to counsel clients through matters that require coordination among multiple regulatory bodies and governmental authorities, ensuring that deal structures achieve both business and compliance objectives.
In addition to his health care transactional practice, Mr. Abrams has experience advising life sciences companies on a range of corporate and compliance matters. His work in this space includes counseling clients, including academic research institutions, on structuring relationships with industry partners, negotiating and drafting clinical trial and research collaboration agreements, and advising on regulatory and compliance considerations unique to the life sciences industry. Mr. Abrams regularly works with early stage and emerging life sciences companies, supporting their growth through strategic transactions and governance advice as they move from development to commercialization. He leverages his broad transactional experience to provide practical guidance to life sciences clients navigating complex projects at the intersection of business, science, and regulation.